| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Uihlein Richard E serves as a Director, 10% Owner at GALT. Across recent SEC filings that breaks down to 5 buys and 0 sells. Those positions are worth an estimated $154.3M at current prices.
The biggest single holding is GALT (~$154.3M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 103,200 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2020 | GALT Galectin Therapeutics Inc | Director, 10% Owner | Buy | 10,000 | $2.55 | $25,500.00 | +0.1% | |
| Apr 9, 2019 | GALT Galectin Therapeutics Inc | Director, 10% Owner | Buy | 20,700 | $4.82 | $99,850.59 | +0.8% | |
| Apr 5, 2019 | GALT Galectin Therapeutics Inc | Director, 10% Owner | Buy | 21,000 | $4.81 | $100,972.20 | +0.8% | |
| Jan 29, 2019 | GALT Galectin Therapeutics Inc | Director, 10% Owner | Buy | 51,500 | $4.87 | $250,558.60 | +1.0% |